165 related articles for article (PubMed ID: 28938557)
41. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
42. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
Moses W; Weng J; Kebebew E
Thyroid; 2011 Apr; 21(4):367-71. PubMed ID: 21190444
[TBL] [Abstract][Full Text] [Related]
43. Association of urothelial carcinoma of the renal pelvis with papillary and medullary thyroid carcinomas. A new sporadic neoplastic syndrome?
Albores-Saavedra J; Dorantes-Heredia R; Chablé-Montero F; Córdova-Ramón JC; Henson DE
Ann Diagn Pathol; 2014 Oct; 18(5):286-90. PubMed ID: 25175810
[TBL] [Abstract][Full Text] [Related]
44. [Hereditary thyroid carcinoma and its molecular diagnostics].
Dvořáková S; Václavíková E; Sýkorová V; Hálková T; Bendlová B
Cesk Patol; 2014 Apr; 50(2):81-6. PubMed ID: 24758503
[TBL] [Abstract][Full Text] [Related]
45. Familial non-medullary thyroid cancer: a critical review.
Capezzone M; Robenshtok E; Cantara S; Castagna MG
J Endocrinol Invest; 2021 May; 44(5):943-950. PubMed ID: 33025555
[TBL] [Abstract][Full Text] [Related]
46. Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident.
Fisher SB; Cote GJ; Bui-Griffith JH; Lu W; Tang X; Hai T; Fisher KE; Williams MD; Wistuba II; Waguespack SG; Dorman CM; Ludwig MS; Graham PH; Perrier ND; Lee JE; Grubbs EG
Surgery; 2019 Jan; 165(1):58-63. PubMed ID: 30392857
[TBL] [Abstract][Full Text] [Related]
47. [Study of Medullary Thyroid Carcinoma from a proband].
Morlán Herrador L; de Arriba A; Miguel G; Ferrera M; Labarta JI
Arch Argent Pediatr; 2016 Dec; 114(6):e421-e424. PubMed ID: 27869424
[TBL] [Abstract][Full Text] [Related]
48. Diagnosis and Management of Hereditary Thyroid Cancer.
Bano G; Hodgson S
Recent Results Cancer Res; 2016; 205():29-44. PubMed ID: 27075347
[TBL] [Abstract][Full Text] [Related]
49. A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas.
Maeda S; Namba H; Takamura N; Tanigawa K; Takahashi M; Noguchi S; Nagataki S; Kanematsu T; Yamashita S
Endocr J; 1995 Apr; 42(2):245-50. PubMed ID: 7627269
[TBL] [Abstract][Full Text] [Related]
50. Familial non-medullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families.
Leprat F; Bonichon F; Guyot M; Trouette H; Trojani M; Vergnot V; Longy M; Belleannée G; de Mascarel A; Roger P
Clin Endocrinol (Oxf); 1999 May; 50(5):589-94. PubMed ID: 10468924
[TBL] [Abstract][Full Text] [Related]
51. A pathogenic variant in CHEK2 shows a founder effect in Portuguese Roma patients with thyroid cancer.
Pires C; Marques IJ; Dias D; Saramago A; Leite V; Cavaco BM
Endocrine; 2021 Sep; 73(3):588-597. PubMed ID: 33683595
[TBL] [Abstract][Full Text] [Related]
52. Biological behavior and prognosis of familial papillary thyroid carcinoma.
Ito Y; Kakudo K; Hirokawa M; Fukushima M; Yabuta T; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A
Surgery; 2009 Jan; 145(1):100-5. PubMed ID: 19081481
[TBL] [Abstract][Full Text] [Related]
53. Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: an unusual clinical coexistence.
Mazziotti G; Rotondi M; Manganella G; Franco R; Capone PFRS ; Colantuoni V; Amato G; Carella C
J Endocrinol Invest; 2001 Dec; 24(11):892-6. PubMed ID: 11817715
[TBL] [Abstract][Full Text] [Related]
54. Genetic aspects of familial thyroid cancer.
Morrison PJ; Atkinson AB
Oncologist; 2009 Jun; 14(6):571-7. PubMed ID: 19465682
[TBL] [Abstract][Full Text] [Related]
55. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
[TBL] [Abstract][Full Text] [Related]
56. Our experience of treatment of cribriform morular variant of papillary thyroid carcinoma; difference in clinicopathological features of FAP-associated and sporadic patients.
Ito Y; Miyauchi A; Ishikawa H; Hirokawa M; Kudo T; Tomoda C; Miya A
Endocr J; 2011; 58(8):685-9. PubMed ID: 21670544
[TBL] [Abstract][Full Text] [Related]
57. Concomitant medullary thyroid carcinoma with paraganglioma-like pattern and papillary thyroid carcinoma.
Greco C; Brigante G; Taliani E; Corrado S; Simoni M; Madeo B
Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31778356
[TBL] [Abstract][Full Text] [Related]
58. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.
Lee YM; Yoon JH; Yi O; Sung TY; Chung KW; Kim WB; Hong SJ
J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694
[TBL] [Abstract][Full Text] [Related]
59. Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period.
Vidinov K; Nikolova D
Endocr Pathol; 2017 Mar; 28(1):54-59. PubMed ID: 27771834
[TBL] [Abstract][Full Text] [Related]
60. Genetic susceptibility to hereditary non-medullary thyroid cancer.
Kamani T; Charkhchi P; Zahedi A; Akbari MR
Hered Cancer Clin Pract; 2022 Mar; 20(1):9. PubMed ID: 35255942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
